These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11573142

  • 1. Approaches to gene therapy with sodium/iodide symporter.
    Spitzweg C, Morris JC.
    Exp Clin Endocrinol Diabetes; 2001; 109(1):56-9. PubMed ID: 11573142
    [Abstract] [Full Text] [Related]

  • 2. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
    [Abstract] [Full Text] [Related]

  • 3. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC.
    Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711
    [Abstract] [Full Text] [Related]

  • 4. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823
    [Abstract] [Full Text] [Related]

  • 5. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 6. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2005 Feb 01; 12(3):272-80. PubMed ID: 15510175
    [Abstract] [Full Text] [Related]

  • 7. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C.
    Clin Cancer Res; 2009 Oct 01; 15(19):6079-86. PubMed ID: 19789324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ.
    Cancer Gene Ther; 2003 Jan 01; 10(1):14-22. PubMed ID: 12489024
    [Abstract] [Full Text] [Related]

  • 12. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
    Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF, Jhiang SM.
    Gene Ther; 2002 Sep 01; 9(17):1139-45. PubMed ID: 12170377
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
    Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Göke B, Morris JC.
    Endocrinology; 2003 Aug 01; 144(8):3423-32. PubMed ID: 12865321
    [Abstract] [Full Text] [Related]

  • 14. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
    Mitrofanova E, Hagan C, Qi J, Seregina T, Link C.
    Anticancer Res; 2003 Aug 01; 23(3B):2397-404. PubMed ID: 12894520
    [Abstract] [Full Text] [Related]

  • 15. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats.
    Faivre J, Clerc J, Gérolami R, Hervé J, Longuet M, Liu B, Roux J, Moal F, Perricaudet M, Bréchot C.
    Cancer Res; 2004 Nov 01; 64(21):8045-51. PubMed ID: 15520214
    [Abstract] [Full Text] [Related]

  • 16. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ, Huang R, Kuang AR.
    Cancer Invest; 2009 Jul 01; 27(6):673-81. PubMed ID: 19241193
    [Abstract] [Full Text] [Related]

  • 17. Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS).
    Gaut AW, Niu G, Krager KJ, Graham MM, Trask DK, Domann FE.
    Head Neck; 2004 Mar 01; 26(3):265-71. PubMed ID: 14999802
    [Abstract] [Full Text] [Related]

  • 18. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.
    Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS.
    J Nucl Med; 2008 Sep 15; 49(9):1480-8. PubMed ID: 18703598
    [Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
    Nakamoto Y, Saga T, Misaki T, Kobayashi H, Sato N, Ishimori T, Kosugi S, Sakahara H, Konishi J.
    J Nucl Med; 2000 Nov 15; 41(11):1898-904. PubMed ID: 11079502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.